Naproxen Azure Pharmaceuticals (Naproxen)

Naproxen blocks the cyclooxygenase (COX‑1 and COX‑2) enzymes that convert arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes the chemical signals that cause pain, swelling, and fever at the site of tissue injury.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Clinicians tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

Safety of naproxen in pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester because of potential fetal complications, and caution is advised while breastfeeding. Physicians should evaluate benefits versus risks before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naproxen has a longer half‑life than ibuprofen, allowing less frequent dosing for chronic conditions. Both share similar mechanisms and safety profiles, but naproxen may carry a slightly higher risk of cardiovascular events, while ibuprofen is often preferred for short‑term pain relief. Choice depends on clinical judgment and patient factors.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect from moisture and direct sunlight. Do not refrigerate or freeze unless the label specifically indicates otherwise.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulcer perforation, renal impairment, cardiovascular events such as heart attack or stroke, severe skin reactions, and hepatic injury. Patients should be educated to seek immediate medical attention if they notice signs like black stools, sudden kidney problems, chest pain, or rash.

Individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, uncontrolled hypertension, or a history of cardiovascular thrombotic events should avoid using naproxen unless specifically directed by a healthcare professional.